Sheila A. M. Rauch, PhD; H. Myra Kim, ScD; Corey Powell, PhD; et al.
free access
JAMA Psychiatry. 2019;76(2):117-126. doi:10.1001/jamapsychiatry.2018.3412
This randomized clinical trial compares the relative efficacy of prolonged exposure therapy plus placebo, prolonged exposure therapy plus sertraline hydrochloride, and sertraline plus enhanced medication management in the treatment of posttraumatic stress disorder among combat veterans.
Zill-e-Huma Latif, MD; Jūratė Šaltytė Benth, MSc, PhD; Kristin Klemmetsby Solli, MSc, PhD; et al.
free access
JAMA Psychiatry. 2019;76(2):127-134. doi:10.1001/jamapsychiatry.2018.3537
This randomized clinical trial and open-label follow-up study investigates whether treatment with extended-release naltrexone vs daily treatment with combined buprenorphine-naloxone unmasks or reinforces comorbid symptoms of anxiety, depression, or insomnia in 159 abstinence-motivated adults with opioid dependence.
Tjasa Velikonja, PhD; Anne-Kathrin Fett, PhD; Eva Velthorst, PhD
free access
JAMA Psychiatry. 2019;76(2):135-151. doi:10.1001/jamapsychiatry.2018.3645
This systematic review and meta-analysis provides an overview of nonsocial and social cognitive functioning in various domains in adults with autism spectrum disorder, allowing for comparison of the severity of deficits between different domains.
Mark Olfson, MD, MPH; Shuai Wang, PhD; Melanie Wall, PhD; et al.
free access
JAMA Psychiatry. 2019;76(2):152-161. doi:10.1001/jamapsychiatry.2018.3550
This survey study characterizes US national trends in serious psychological distress and trends in outpatient mental health service use by adults with and without serious psychological distress.
Wayne A. Ray, PhD; C. Michael Stein, MB, ChB; Katherine T. Murray, MD; et al.
free access
JAMA Psychiatry. 2019;76(2):162-171. doi:10.1001/jamapsychiatry.2018.3421
This cohort study of Tennessee Medicaid enrollees from 1999 through 2014 investigates the risk of unexpected death among children and youths aged 5 through 24 years without psychosis who are new users of antipsychotic medications compared with new users of control medications.
Jon Brännström, MD; Hugo Lövheim, MD, PhD; Yngve Gustafson, MD, PhD; et al.
free access
JAMA Psychiatry. 2019;76(2):172-179. doi:10.1001/jamapsychiatry.2018.3679
This population-based study examines the occurrence of hip fractures in elderly individuals before and after initiation of antidepressant medications.
Kathryn Yates, MSc; Ulla Lång, MA; Martin Cederlöf, PhD; et al.
free access
JAMA Psychiatry. 2019;76(2):180-189. doi:10.1001/jamapsychiatry.2018.3514
This systematic review and meta-analysis examines longitudinal studies on cohorts of individuals with psychotic experiences to determine their likelihood of suicidal ideation, suicide attempts, and suicide death.
Kathleen Ries Merikangas, PhD; Joel Swendsen, PhD; Ian B. Hickie, MBBS; et al.
free access
has audio
JAMA Psychiatry. 2019;76(2):190-198. doi:10.1001/jamapsychiatry.2018.3546
This case-control study examines the real-time changes and associations between physical activity, sleep patterns, and energy and mood levels in people with and those without bipolar or depressive disorder.
-
Audio Author Interview:
Real-time Monitoring of Motor Activity, Energy, Mood, and Sleep Associations in Bipolar Disorder
Matthijs G. Bossong, PhD; Mathilde Antoniades, PhD; Matilda Azis, PhD; et al.
free access
JAMA Psychiatry. 2019;76(2):199-207. doi:10.1001/jamapsychiatry.2018.3252
This cross-sectional study investigates whether increased hippocampal glutamate levels are associated with adverse clinical outcomes in individuals at clinical high risk for psychosis compared with healthy control individuals, between clinical high-risk individuals who develop and do not develop psychosis, and between individuals with good and poor outcomes.